12-57224954-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_007224.4(NXPH4):c.134C>T(p.Ala45Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000239 in 1,253,002 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_007224.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
NXPH4 | NM_007224.4 | c.134C>T | p.Ala45Val | missense_variant | 2/2 | ENST00000349394.6 | |
NXPH4 | XM_017018747.2 | c.134C>T | p.Ala45Val | missense_variant | 2/3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
NXPH4 | ENST00000349394.6 | c.134C>T | p.Ala45Val | missense_variant | 2/2 | 1 | NM_007224.4 | P1 | |
NXPH4 | ENST00000555154.1 | n.185C>T | non_coding_transcript_exon_variant | 2/2 | 3 | ||||
NXPH4 | ENST00000556415.1 | c.*261C>T | 3_prime_UTR_variant, NMD_transcript_variant | 3/3 | 2 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome AF: 0.00000239 AC: 3AN: 1253002Hom.: 0 Cov.: 28 AF XY: 0.00000327 AC XY: 2AN XY: 612108
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 22, 2021 | The c.134C>T (p.A45V) alteration is located in exon 2 (coding exon 2) of the NXPH4 gene. This alteration results from a C to T substitution at nucleotide position 134, causing the alanine (A) at amino acid position 45 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at